ResMed Inc. (RMD) - Financial and Strategic SWOT Analysis Review

Summary

ResMed Inc. (ResMed) is a medical device company. It develops, manufactures and distributes medical equipment for diagnosis, treatment and management of Sleep-disordered Breathing (SDB) and other respiratory disorders. The company’s major products include continuous positive airway pressure (CPAP) devices; auto-bilevel device, variable positive airway pressure (VPAP) devices, automatic positive airway pressure (APAP) devices; humidifiers, ventilation products; masks, accessories, motors and diagnostic products; and data/patient management products.

ResMed Inc. Key Recent Developments

Feb 20, 2013: ResMed Names Michael Farrell As CEO
Jan 24, 2013: ResMed Reports Revenue Of $376.5m In Q2 Fiscal 2013
Oct 25, 2012: ResMed Reports Revenue Of $339.7m In Q1 Fiscal 2013
Aug 23, 2012: ResMed To Create 50 New RD&I Jobs In Dublin
Aug 13, 2012: ResMed Reports Revenue Of $1.4 Billion In Fiscal 2012GDME754FSA

This comprehensive SWOT profile of ResMed Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. SHOW LESS READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
ResMed Inc. - Key Facts
ResMed Inc. - Key Employees
ResMed Inc. - Key Employee Biographies
ResMed Inc. - Major Products and Services
ResMed Inc. - Medical Equipment Pipeline Products Data
ResMed Inc. Pipeline Products by Equipment Type
ResMed Inc. Pipeline Products by Development Stage
ResMed Inc. - History
ResMed Inc. - Company Statement
ResMed Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
ResMed Inc. - Key Manufacturing Facilities
Section 2 – Company Analysis
ResMed Inc. - Business Description
Business Description - Sleep-Disordered Breathing
Sleep-Disordered Breathing - Overview
Sleep-Disordered Breathing - Financials
Sleep-Disordered Breathing - Market View
Sleep-Disordered Breathing - Technology
ResMed Inc. - Corporate Strategy
ResMed Inc. - SWOT Analysis
SWOT Analysis - Overview
ResMed Inc. - Strengths
Strength - Strong Research and Development Activities
Strength - Diversified Geographical Presence
Strength - Inorganic Growth Strategy
Strength - Strong Growth in Top and Bottom Line
ResMed Inc. - Weaknesses
Weakness - Legal Proceedings
Weakness - Increased SG&A Expenses
Weakness - Single-source Suppliers
ResMed Inc. - Opportunities
Opportunity - Market Potential
Opportunity - Market Growth in Emerging Economies
Opportunity - Growing Aged Population
Opportunity - Product Innovation
Opportunity - Enhance Public and Clinical Awareness
ResMed Inc. - Threats
Threat - Patent Expiries
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Cost Containment Pressures
ResMed Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ResMed Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
ResMed Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
ResMed Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
ResMed Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
ResMed Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
ResMed Inc., Recent Developments
Feb 20, 2013: ResMed Names Michael Farrell As CEO
Jan 24, 2013: ResMed Reports Revenue Of $376.5m In Q2 Fiscal 2013
Oct 25, 2012: ResMed Reports Revenue Of $339.7m In Q1 Fiscal 2013
Aug 23, 2012: ResMed To Create 50 New RD&I Jobs In Dublin
Aug 13, 2012: ResMed Reports Revenue Of $1.4 Billion In Fiscal 2012
Jun 13, 2012: ResMed Launches Narval CC Mandibular Repositioning Device In US
May 21, 2012: ResMed Enrolls 1000th Participant In Its SERVE-HF Clinical Study
Apr 26, 2012: ResMed Reports Revenue Of $349.1m In Q3 Fiscal 2012
Apr 11, 2012: ResMed Releases EasyCare Online Patient Compliance Management Solution
Jan 26, 2012: ResMed Reports Revenue Of $332.7m In Q2 Fiscal 2012
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
ResMed Inc., Key Facts
ResMed Inc., Key Employees
ResMed Inc., Key Employee Biographies
ResMed Inc., Major Products and Services
ResMed Inc. Number of Pipeline Products by Equipment Type
ResMed Inc. Pipeline Products by Equipment Type
ResMed Inc. Number of Pipeline Products by Development Stage
ResMed Inc. Pipeline Products by Development Stage
ResMed Inc., History
ResMed Inc., Other Locations
ResMed Inc., Subsidiaries
ResMed Inc., Key Manufacturing Facilities
ResMed Inc., Key Competitors
ResMed Inc., Ratios based on current share price
ResMed Inc., Annual Ratios
ResMed Inc., Interim Ratios
ResMed Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
ResMed Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
ResMed Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
ResMed Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
ResMed Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ResMed Inc. Pipeline Products by Equipment Type
ResMed Inc. Pipeline Products by Development Stage
ResMed Inc., Performance Chart (2008 - 2012)
ResMed Inc., Ratio Charts
ResMed Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
ResMed Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013
ResMed Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
ResMed Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

DeVilbiss Healthcare
Fisher & Paykel Healthcare Corporation Limited
Philips Respironics, Inc.